We are live on ! Find out more
IRD

Opus Genetics
IRD

35 hedge funds and large institutions have $5.94M invested in Opus Genetics in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $5.65M → $5.94M (+$292K)

8% less funds holding

Funds holding: 38 → 35 (-3)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$235K
2
BIT
BlackRock Institutional Trust
California
+$215K
3
Renaissance Technologies
Renaissance Technologies
New York
+$102K
4
Wells Fargo
Wells Fargo
California
+$93K
5
CCM
Condor Capital Management
New Jersey
+$67.9K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$252K
2
Morgan Stanley
Morgan Stanley
New York
-$176K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$55.2K
4
Goldman Sachs
Goldman Sachs
New York
-$47.2K
5
Deutsche Bank
Deutsche Bank
Germany
-$29.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.39M +$235K +647 +7%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$668K – – –
Wells Fargo
3
Wells Fargo
California
$308K +$93K +256 +41%
BIT
4
BlackRock Institutional Trust
California
$244K +$215K +591 +558%
Renaissance Technologies
5
Renaissance Technologies
New York
$212K +$102K +281 +87%
Northern Trust
6
Northern Trust
Illinois
$171K – – –
CCM
7
Condor Capital Management
New Jersey
$154K +$67.9K +187 +74%
BCM
8
Bridgeway Capital Management
Texas
$131K – – –
NFC
9
Northeast Financial Consultants
Connecticut
$109K – – –
AQR Capital Management
10
AQR Capital Management
Connecticut
$103K -$55.2K -152 -34%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$93K – – –
BMC
12
Benin Management Corp
Connecticut
$61K – – –
Goldman Sachs
13
Goldman Sachs
New York
$44K -$47.2K -130 -51%
Bank of America
14
Bank of America
North Carolina
$37K – – –
State Street
15
State Street
Massachusetts
$30K +$6.17K +17 +25%
BA
16
BlackRock Advisors
Delaware
$26K – – –
UBS Group
17
UBS Group
Switzerland
$23K -$16.3K -45 -41%
Creative Planning
18
Creative Planning
Kansas
$21K +$6.17K +17 +40%
GC
19
Guggenheim Capital
Illinois
$20K – – –
ASN
20
Advisory Services Network
Georgia
$16K – – –
FHC
21
First Heartland Consultants
Missouri
$15K -$7.63K -21 -33%
LTFS
22
Ladenburg Thalmann Financial Services
Florida
$14K +$1.09K +3 +8%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$11K -$27.6K -76 -71%
VKH
24
Virtu KCG Holdings
New York
$10K -$252K -695 -96%
MC
25
Moors & Cabot
Massachusetts
$7K -$5.45K -15 -39%
1
2

IRD Hedge Fund Activity: Q1 2015 in Review

35 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2015, worth a combined $5.94M — up 5.2% from $5.65M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IRD and 2 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $235K. The largest seller was Virtu KCG Holdings, cutting an estimated $252K.

  • 35 institutional investors held Opus Genetics (IRD) as of Q1 2015, down from 38 in Q4 2014.
  • Funds reported $5.94M of Opus Genetics stock for Q1 2015, up 5.2% quarter-over-quarter.
  • 2 funds opened new Opus Genetics positions in Q1 2015 and 5 closed out, a net change of -3 holders.
  • The largest Opus Genetics buyer in Q1 2015 was Vanguard Group, an estimated $235K added.
  • The largest Opus Genetics seller in Q1 2015 was Virtu KCG Holdings, an estimated $252K sold.

Based on aggregated 13F filings for Q1 2015.